Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin.

Source:http://linkedlifedata.com/resource/pubmed/id/12592351

Download in:

View as

General Info

PMID
12592351